The Hindu·2 min read·easy
Omnigel strengthens its portfolio with the introduction of Omnigel Maxstrong
C
cuelive
✦AI Summary
Cipla Health has launched Omnigel Maxstrong, a new 2% diclofenac pain relief product available in gel and spray formats. This expansion marks the brand's entry into a more advanced pain management category with updated premium packaging.
The new variant is built for individuals whose active routines often lead to repeated muscle and joint discomfort
healthbusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in